René Meisner

922 total citations
7 papers, 258 citations indexed

About

René Meisner is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, René Meisner has authored 7 papers receiving a total of 258 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Genetics and 2 papers in Cancer Research. Recurrent topics in René Meisner's work include Cancer, Hypoxia, and Metabolism (2 papers), Angiogenesis and VEGF in Cancer (2 papers) and Cancer therapeutics and mechanisms (1 paper). René Meisner is often cited by papers focused on Cancer, Hypoxia, and Metabolism (2 papers), Angiogenesis and VEGF in Cancer (2 papers) and Cancer therapeutics and mechanisms (1 paper). René Meisner collaborates with scholars based in United States and Kenya. René Meisner's co-authors include Fumiko Axelrod, Min Wang, Marcus Fischer, Timothy Hoey, Ann M. Kapoun, Jalpa Shah, Aaron K. Sato, John Lewicki, Jennifer Cain and Belinda Cancilla and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Molecular Cancer Therapeutics.

In The Last Decade

René Meisner

6 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
René Meisner United States	4	188	121	59	29	25	7	258
Erin M. Garfield United States	6	104 0.6×	149 1.2×	31 0.5×	26 0.9×	12 0.5×	9	199
Shengming Xu China	10	170 0.9×	148 1.2×	58 1.0×	42 1.4×	53 2.1×	27	286
Morgan MacBeth United States	7	187 1.0×	128 1.1×	44 0.7×	21 0.7×	41 1.6×	15	273
Wolfgang Gruber Austria	9	272 1.4×	80 0.7×	39 0.7×	13 0.4×	26 1.0×	12	338
Joanna Kelly United Kingdom	7	108 0.6×	43 0.4×	64 1.1×	33 1.1×	33 1.3×	9	230
Antonia Kreso United States	4	118 0.6×	62 0.5×	26 0.4×	14 0.5×	18 0.7×	16	179
Jason Kunisaki United States	4	109 0.6×	63 0.5×	98 1.7×	94 3.2×	24 1.0×	6	236
Sara Waise United Kingdom	7	82 0.4×	87 0.7×	46 0.8×	39 1.3×	35 1.4×	9	182
Michael Peoples United States	9	181 1.0×	105 0.9×	59 1.0×	36 1.2×	35 1.4×	16	267
Elisabetta Ercole Italy	5	126 0.7×	43 0.4×	66 1.1×	22 0.8×	25 1.0×	6	192

Countries citing papers authored by René Meisner

Since Specialization

Citations

This map shows the geographic impact of René Meisner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by René Meisner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites René Meisner more than expected).

Fields of papers citing papers by René Meisner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by René Meisner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by René Meisner. The network helps show where René Meisner may publish in the future.

Co-authorship network of co-authors of René Meisner

This figure shows the co-authorship network connecting the top 25 collaborators of René Meisner. A scholar is included among the top collaborators of René Meisner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with René Meisner. René Meisner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Bangari, Dinesh S., Lisa G. Lanigan, Sarah D. Cramer, et al.. (2023). Toxicologic Neuropathology of Novel Biotherapeutics. Toxicologic Pathology. 51(7-8). 414–431. 3 indexed citations

2.

Yen, Wan-Ching, Marcus Fischer, Fumiko Axelrod, et al.. (2015). Targeting Notch Signaling with a Notch2/Notch3 Antagonist (Tarextumab) Inhibits Tumor Growth and Decreases Tumor-Initiating Cell Frequency. Clinical Cancer Research. 21(9). 2084–2095. 195 indexed citations

3.

Yen, Wan-Ching, Marcus Fischer, Gretchen Argast, et al.. (2015). Abstract C164: Dual targeting of the DLL4 and VEGF pathways with a bispecific monoclonal antibody inhibits tumor growth and reduces cancer stem cell frequency. Molecular Cancer Therapeutics. 14(12_Supplement_2). C164–C164. 5 indexed citations

4.

Yen, Wan-Ching, Fumiko Axelrod, Jennifer Cain, et al.. (2014). Abstract 207: Dual targeting of DLL4 and VEGF signaling by a novel bispecific antibody inhibits tumor growth and reduces cancer stem cell frequency. Cancer Research. 74(19_Supplement). 207–207. 1 indexed citations

5.

Tedesco, Donato, Jianhua Zhang, Guita Lalehzadeh, et al.. (2007). The Ubiquitin-Conjugating Enzyme E2-EPF Is Overexpressed in Primary Breast Cancer and Modulates Sensitivity to Topoisomerase II Inhibition. Neoplasia. 9(7). 601–613. 45 indexed citations

6.

Meisner, René & Wayne E. McFee. (2004). Preliminary report on Bottlenose dolphin (Tursiops truncatus) uterine samples for parity analysis. AquaDocs (United Nations Educational, Scientific and Cultural Organization).

7.

Shilton, Catherine M., et al.. (2002). NASOPHARYNGEAL MYXOSARCOMA IN A BENGAL TIGER (PANTHERA TIGRIS). Journal of Zoo and Wildlife Medicine. 33(4). 371–377. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact